statistiche ricercatore

Nome	#
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study	80
Ethical criteria for the admission and management of patients in the ICU under conditions of limited medical resources: a shared international proposal in view of the COVID-19 pandemic	80
The SARS‐CoV‐2 Mu variant should not be left aside: It warrants attention for its immuno‐escaping ability	75
The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach	73
SARS‐CoV‐2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate?	70
Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion	64
Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission	60
Shortening Epitopes to Survive: The Case of SARS-CoV-2 Lambda Variant	58
Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5	38
Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy	32
SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy	27
Genetic and structural genome-based survey reveals the low potential for epidemiological expansion of the SARS-CoV-2 XBB.1.5 sublineage	17
Totale	674

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	10	0	0	0	0	0	0	1	0	0	0	0	9
2022/2023	7	1	0	0	0	0	2	0	0	0	0	4	0
2023/2024	43	1	4	9	6	7	12	0	1	1	2	0	0
2024/2025	614	13	2	16	5	2	12	5	0	33	68	458	0
Totale													674